- Sales amounted to SEK 379 (334) million, corresponding to an increase of 14 percent in SEK. Sales increased by 20 percent in local currency.
- Operating income before depreciation and amortisation (EBITDA) amounted to SEK 163 (116) million, corresponding to a margin of 43 (35) percent. Fluctuations in exchange rates negatively impacted EBITDA by SEK 10 million.
- Net income amounted to SEK 119 (80) million, which gave earnings per share of SEK 1.09 (0.74).
Gothenburg, April 22, 2021
VITROLIFE AB (publ)
Thomas Axelsson, CEO
Show as PDF
Show original from Cision
This information was distributed by Cision http://www.cisionwire.se/